Table 1S: non-responders / responders > 1
Table 1S: non-responders / responders < 1
Table 1BS: Log2 Ratio Mean(Cancer/Normal) > 0
Table 1BS: Log2 Ratio Mean(Cancer/Normal) < 0
Table 1S: module=yellow & fold change >= 1.5
Table 1S: module=yellow & fold change =< 0.667
Table 1S: module=turquoise & fold change >= 1.5
Table 1S: module=turquoise & fold change =< 0.667
Table 1S: module=red & fold change >= 1.5
Table 1S: module=red & fold change =< 0.667
Table 1S: module=magenta & fold change >= 1.5
Table 1S: module=magenta & fold change =< 0.667
Table 1S: module=lightyellow & fold change >= 1.5
Table 1S: module=lightyellow & fold change =< 0.667
Table 1S: module=green & fold change >= 1.5
Table 1S: module=green & fold change =< 0.667
Table 1S: module=blue & fold change >= 1.5
Table 1S: module=blue & fold change =< 0.667
Table 1S: module=black & fold change >= 1.5
Table 1S: module=black & fold change =< 0.667
Table 1S: module=grey & fold change >= 1.5
Table 1S: module=grey & fold change =< 0.667
Table S1: Pvalue <= 0.001 & Fold change > 1
Table S1: Pvalue <= 0.001 & Fold change < 1
Suppl. Data 2: 1610 EWSFLI upregulated genes
Suppl. Data 2: 436 EWSFLI downregulated genes
Tables 3S, 4S: DMOG fold change > 0 & q-val < 0.01
Tables 3S, 4S: DMOG fold change < 0 & q-val < 0.01
Tables 3S, 4S: HIF1si fold change > 0 & q-value < 0.01
Tables 3S, 4S: HIFsi fold change < 0 & q-value < 0.01
Tables 3S, 4S: HIF2si fold change > 0 & q-value < 0.01
Tables 3S, 4S: HIF12si fold change > 0 & q-value < 0.01
Tables 3S, 4S: HIF12si fold change < 0 & q-value < 0.01
Table 2: Increased in adjacent erbB2/neu samples
Table 2: Decreased in adjacent erbB2/neu samples
Table 1: Overexpressed genes in patients who developed a recurrence
Table 1: Overexpressed genes in patients who remained disease-free
Table 2: Overexpressed genes in patients who developed a recurrence
Table 2: Overexpressed genes in patients who remained disease-free
Table 4, 2S (XP/CS signature): SLR 4h >= 1 or SLR 8h >= 1
Table 4, 2S (XP/CS signature): SLR 4h =< -1 or SLR 8h =< -1
Table 1S: Log Ratio CT60/4 vs. MDA-MB-231 > 0
Table 1S: Log Ratio CT60/4 vs. MDA-MB-231 < 0
Table 1S: GISTs with PDGFRA mutation > 1
Table 2: Higher relative expression in LMP-G1
Table 2: Higher relative expression in G2-G3
Table 1S: CC = I & SLR >= 1 in at least one condition
Table 1S: CC = D & SLR <= -1 in at least one condition
Table 1: Genes uniquely upregulated by IL-2 in T1
Table 1: Genes upregulated by IL-2 in T1 and primary T cells
Table 3: Genes uniquely upregulated by IL-2 in T1
Table 3: Genes upregulated by IL-2 in T1 and primary T cells
Table 2: Microarray fold change < 0 or -
Table 1: E6/E7-immortalized HFK: Fold delta < 0
Table 3S: positively correlated with MYC
Table 3S: negatively correlated with MYC
Table 3S: positively correlated with MYCN
Table 3S: negatively correlated with MYCN
Table 3S: positively correlated with MYCL1
Table 3S: negatively correlated with MYCL1
Table 2S, 3S: up in cluster-1, down in cluster-2
Table 2S, 3S: down in cluster-1, up in cluster-2
Table 6S: early onset tumor correlated genes
Table 6S: late onset tumor correlated genes
Fig 1S: UP in medulloblastoma, DOWN in cerebellum
Fig 1S: DOWN in medulloblastoma, UP in cerebellum
Table 2S: increased expression and amplification
Table 2S: reduced expression and deletion
Suppl. file 1: top 100 up-regulated genes, converted to human orthologs
GSE1897: top 100 down-regulated in CIP; convertied to human orthologs
Suppl. Data: section 3; DLBCL Cured versus Fatal/Refractory Distinction; Distinction = fatal/ref.
Table 2: genes downregulated in L1 in comparison with L0
Table 3: genes upregulated in G1 in comparison with L1
Suppl. data for Fig. 2: sheet5_BJAB_leucine_up
GSE1897: top 100 down-regulated in Myc/Tgfa; convertied to human orthologs
Table 4: genes upregulated in G2 in comparison with G1
GSE1897: top 100 down-regulated in Acox1; converted to human orthologs
Suppl. data for Fig. 2: sheet7_BJAB_glucose_up
GSE1897: top 100 up-regulated in Myc; converted to human orthologs
Table 2: genes upregulated in L1 in comparison with L0
Suppl. data for Fig. 2: sheet3_glutamine up
GSE1897: top 100 up-regulated in Myc/Tgfa; convertied to human orthologs
Final annotated Gene list PBL C vs Tx down in Tx
Table 5: genes downregulated in G3 in comparison with G2
GSE569: bottom 100 from COLON_TNFA DERMAL_TNFA ILIAC_TNFA AORTIC_TNFA LUNG_TNFA
Suppl. data for Fig. 2: sheet6_BJAB_leucine_dw
Suppl. file 1: top 100 down-regulated genes, converted to human orthologs
Table 2S: LDMP DC > 0 & LDMP p val. < 0.01
Table 4: genes downregulated in G2 in comparison with G1
Suppl. Data: section 3; DLBCL Cured versus Fatal/Refractory Distinction; Distinction = cured
Final annotated Gene list BX Tx vs AR up in AR
GSE1897: top 100 up-regulated in Acox1; converted to human orthologs
Table 5: genes upregulated in G3 in comparison with G2
GSE1897: top 100 down-regulated in Myc/E2f1; convertied to human orthologs
GSE1897: top 100 up-regulated in Myc/E2f1; convertied to human orthologs
Final annotated Gene list PBL C vs Tx up in Tx
Final annotated Gene list PBL Tx vs AR down in AR
GSE569: top 100 of COLON_IFNG DERMAL_IFNG ILIAC_IFNG AORTIC_IFNG LUNG_IFNG
GSE569: top 100 from COLON_TNFA DERMAL_TNFA ILIAC_TNFA AORTIC_TNFA LUNG_TNFA
Suppl. Data: section 3; DLBCL versus FL Distinction; Distinction = FL
GSE1897: top 100 down-regulated in DENA; converted to human orthologs
GSE569: bottom 100 of COLON_IFNG DERMAL_IFNG ILIAC_IFNG AORTIC_IFNG LUNG_IFNG
Table 2S: LDMP DC < 0 & LDMP p val. < 0.01
GSE1897: top 100 down-regulated in Myc; converted to human orthologs
GSE1897: top 100 up-regulated in CIP; convertied to human orthologs
Table 3: genes downregulated in G1 in comparison with L1
Suppl. data for Fig. 2: sheet8_BJAB_glucose_dw
Final annotated Gene list BX Tx vs AR down in AR
Suppl. Data: section 3; DLBCL versus FL Distinction; Distinction = DLBCL
Suppl. data for Fig. 1: sheet2_rapamycin dw
GSE1897: top 100 down-regulated in E2f1; converted to human orthologs
GSE1897: top 100 up-regulated in DENA; converted to human orthologs
Final annotated Gene list BX C vs Tx down in Tx
Suppl. data for Fig. 1: sheet1_rapamycin up
Suppl. data for Fig. 2: sheet4_glutamine dw
Final annotated Gene list PBL Tx vs AR up in AR
Final annotated Gene list BX C vs Tx up in Tx
GSE1897: top 100 up-regulated in E2f1; converted to human orthologs
Table S2: INCREASED EXPRESSION IN NPMc+ LEUKEMIAS
Table S2: DECREASED EXPRESSION IN NPMc+ LEUKEMIAS
Table 7aS: fox3p+/fox3p- > 1 & Foxp3 bound (FDR <.10)
Table 7aS: fox3p+/fox3p- <1 & Foxp3 bound (FDR<.10)
Table 1S: Class NT genes: (N+L)/(T+L) <=1
Table 1S: Class T genes: (N+L)/(T+L) > 3
Suppl. Info 2: Table 5S: 4NQO and Gamma [F]
Suppl. Info 2: Table 5S: 4NQO and UV [G]
Suppl. Info 2: Table 5S: Gamma and UV [H]
Suppl. Info 3: Table 4S: H-ESR.4NQO.not old
Suppl. Info 3: Table 4S: H-ESR.4NQO.Not WS
Suppl. Info 3: Table 4S: H-ESR.Gamma.not old
Suppl. Info 3: Table 4S: H-ESR.Gamma.not WS
Suppl. Info 3: Table 4S: H-ESR.UV.not old
Suppl. Info 3: Table 4S: H-ESR.UV.not WS
Table 1S: Diff: PSN_FL - PSN_ND; P=<0.001
p. 4335: Top 25 (of 53) up-regulated genes
Table 1S: HCP, 5mC (log2) in fibroblasts > 0
Table 4S; correspond to green color in Fig 4
Table 4S; correspond to red color in Fig 4
p. 4335: Top 25 (of 47) down-regulated genes
Fig. 5A: UP in low aneuploidy, DOWN in high aneuploidy
Fig. 5A: DOWN in low aneuploidy, UP in high aneuploidy
Table 2: Up-regulated in resistant cells
Table 2: Down-regulated in resistant cells
Supplmentary File 2: pvalue<0.05 and log2(Fold Change) > 1.5
Supplmentary File 2: pvalue<0.05 and log2(Fold Change) < -1.5
Table 5S: Tumor Group=D & Fold Change > 0
Table 5S: Tumor Group=D & Fold Change < 0
Table 5S: Tumor Group=C and D & Fold Change > 0
Table 5S: Tumor Group=C and D & Fold Change < 0
Table 5S: Tumor Group=C & Fold Change > 0
Table 5S: Tumor Group=C & Fold Change < 0
Fig. 1a: up in sensitive & down in resistant
Fig. 1a: down in sensitive & up in resistant
Suppl. data file 'BMT_356_public.xls': A7 vs S7 P<.01 and FC>2.0
Suppl. data file 'BMT_356_public.xls': A7 vs S7 P<.01 and FC<0.5
Suppl. data file 'BMT_356_public.xls': A35 vs S35 P<.01 and FC>2
Suppl. data file 'BMT_356_public.xls': A35 vs S35 P<.01 and FC<0.5
Suppl. Data: High Grade Glioma Class Markers, GBM
Suppl. Data: High Grade Glioma Class Markers, AO
Table 3S: top 550 with |correlation| > 0.3 & correlation > 0.3
Table 3S: top 550 with |correlation| > 0.3 & correlation < -0.3
Table 4S: top 100 with |correlation| > 0.3 & correlation > 0.3
Table 4S: top 100 with |correlation| > 0.3 & correlation < -0.3
Suppl. data file "krassigu133.txt"; corresponds to Table 6S
Table 3-1S: SOM C1: (ITTP DP) vs (SP4 CB4 AB4)
Table 3-2S: SOM C6: (SP4 CB4 AB4) vs (ITTP DP)
Table 4-1S, 4-2S: SP4>CB4>AB4 or CB4>AB4
Fig. 3: Ventricular septation and atrioventricular cushion formation
Fig. 3: Great vessel formation and valvulogenesis
Table 1S: mp53/Ras vs. YAMC, norm Data >1
Table 1S: mp53/Ras vs. YAMC, norm Data < 1
Table 2S: ChIP-chip + gene expression = X
Fig. 4bS: Primary myeloma > mature B cell
Fig. 4bS: Activated B cell > resting B cell
Table 2S: HDMP DC > 0 & HDMP p val. < 0.01
Table 2S: HDMP DC < 0 & HDMP p val. < 0.01
Suppl. Data 2A: Table 2S: Fold-diff in geom means < 1
Suppl. Data 2A: Table 2S: Fold-diff in geom means > 1
Suppl. Data 2B: Table 2S: Fold-diff in geom means > 1
Suppl. Data 2B: Table 2S: Fold-diff in geom means < 1
Suppl. Data 2C: Table 2S: Fold-diff in geom means > 1
Suppl. Data 2C: Table 2S: Fold-diff in geom means < 1
Suppl. Data 2D: Table 2S: Fold-diff in geom means > 1
Suppl. Data 2D: Table 2S: Fold-diff in geom means < 1
Table 4: up from (TBC and MM) to (TPC and BPC)
Table 4: down from (TBC and MM) to (TPC and BPC)
Table 6S: Underexpressed in CTNNB1 class
Table 7S: Overexpressed in Proliferation class
Table 7S: Underexpressed in Proliferation class
Table 8S: Overexpressed in Interferon class
Table 8S: Underexpressed in Interferon class
Table 9S: Overexpressed in Chr 7 polysomy class
Table 9S: Underexpressed in Chr 7 polysomy class
Table 10S: Overexpressed in unannotated class
Table 6-10S: Underexpressed in unannotated class
Table 4S: t(8;21)-specific probe sets (424 probe sets)
Table 4S: inv(16)-specific probe sets (471 probe sets)
Table 4S: t(9;11)-specific probe sets (144 probe sets)
Table 4S: 11q23 rearragement-specific probe sets (388 probe sets)
Table 1S: LCP, 5mC (log2) in fibroblasts > 0
Table 1S: LCP, 5mC (log2) in fibroblasts < 0
Table 1S: ICP, 5mC (log2) in fibroblasts > 0
Table 2S: top 70 with |correlation| > 0.3
Supp. data: out_b_data Web S6: Cluster No.=0
Supp. data: out_b_data Web S6: Cluster No.=1
Supp. data: out_b_data Web S6: Cluster No.=3
Supp. data: out_b_data Web S6: Cluster No.=4
Supp. data: out_b_data Web S6: Cluster No.=5
Supp. data: out_b_data Web S6: Cluster No.=6
Supp. data: out_b_data Web S6: Cluster No.=7
Supp. data: out_b_data Web S6: Cluster No.=8
Supp. data: out_b_data Web S6: Cluster No.=9
Supp. data: out_b_data Web S6: Cluster No.=10
Supp. data: out_b_data Web S6: Cluster No.=11
Supp. data: out_b_data Web S6: Cluster No.=12
Supp. data: out_b_data Web S6: Cluster No.=13
Supp. data: out_b_data Web S6: Cluster No.=14
Supp. data: out_b_data Web S6: Cluster No.=15
Supp. data: out_b_data Web S6: Cluster No.=16
Supp. data: out_b_data Web S6: Cluster No.=17
Table 1S: 30min >= 3 & Diff Call [30 min] = I, MI
Table 1S: 30min =< -3 & Diff Call [30 min] = D, MD
Table 1S: 60min >= 3 & Diff Call [60 min] = I, MI
Table 1S: 60min =< -3 & Diff Call [60 min] = D, MD
Table 1S: 2hpi >= 3 & Diff Call [2hpi] = I, MI
Table 1S: 2hpi =< -3 & Diff Call [2hpi] = D, MD
Table 1S: 4hpi >= 3 & Diff Call [4hpi] = I, MI
Table 1S: 4hpi =< -3 & Diff Call [4hpi] = D, MD
Table 1S: 2hpi =< -3 & Diff Call [6hpi] = D, MD
Table 1S: 6hpi >= 3 & Diff Call [6hpi] = I, MI
Table 1S: 10hpi <= -3 & Diff Call [10 hpi] = D, MD
Table 1S: 10hpi >= 3 & Diff Call [10hpi] = I, MI
Table 1S: 12hpi <= -3 & Diff Call [12 hpi] = D, MD
Table 1S: 12hpi >= 3 & Diff Call [12hpi] = I, MI
Table 1S: 14hpi <= -3 & Diff Call [14 hpi] = D, MD
Table 1S: 14hpi >= 3 & Diff Call [14hpi] = I, MI
Table 1S: 16hpi <= -3 & Diff Call [16 hpi] = D, MD
Table 1S: 16hpi >= 3 & Diff Call [16hpi] = I, MI
Table 1S: 18hpi >= 3 & Diff Call [18hpi] = I, MI
Table 1S: 18hpi <= -3 & Diff Call [18 hpi] = D, MD
Table 1S: 20 hpi <= -3 & Diff Call [20 hpi] = D, MD
Table 1S: 20hpi >= 3 & Diff Call [20 hpi] = I, MI
Table 1S: 24hpi <= -3 & Diff Call [24 hpi] = D, MD
Table 1S: 24hpi >= 3 & Diff Call [24 hpi] = I, MI
Table 1S: 48hpi <= 3 & Diff Call [48hpi] = D, MD
Table 1S: 48hpi >= 3 & Diff Call [48hpi] = I, MI
Table 1S: 8hpi <= -3 & Diff Call [8hpi] = D, MD
Table 1S: 8hpi >= 3 & Diff Call [8hpi] = I, MI
Table 2: Differential expression=arrow up
Suppl. file: CHS & Igrovs with common trend: down
Suppl. file: CHS & Igrovs with common trend: up
Excel Table 2S: Expression Cluster=Early Progenitors Shared
Excel Table 2S: Expression Cluster=HSC and Progenitors Shared
Excel Table 2S: Expression Cluster=HSC Shared
Excel Table 2S: Expression Cluster=Intermediate Progenitors Shered
Excel Table 2S: Expression Cluster=Late Progenitors Shared
Excel Table 2S: Expression Cluster=LT-HSC Shared
Excel Table 2S: Expression Cluster=MBC Shared
Excel Table 2S: Expression Cluster=ST-HSC Shared
Table 2S: intersection of genes up-regulated by IFN